Member Info for Toukankahmoon

CJ62

Instead of continually knocking other posters why don’t you tell us your timeline for Avacta trials, development etc and expected impact on SP. I’m particularly interested in any evidence supporting a significant SP movement before this Summer

Thanks in anticipation

BV

Don’t belittle yourself. I am as sure as there is going to be a TO tomorrow that CC has jumped at your advice.

In other news: the next edition of this should finally put to bed the bickering on timescales. I do hope it comes out asap.

BV perhaps you could send CC another email and encourage her to get a move on.

Thanks

“ . As I mentioned, we'll have that,. Pipeline update, platform update, and so we're really excited about, the fourth quarter, for the company."

Jeez I must have missed all those 4Q25 announcements

BenH

It’s ok

Someone has deleted the post anyway

At the end of the day, initial efficacy results will not be published before June IMO. And CC has said as much. She has also said that any acceptable deal is unlikely before those results are published.

And there will be no takeover even if CJ62 forms a consortium of shareholders and tries to push it through at say £1

Thompi

FPI is not the same as FPD.

But no point arguing. You all know better than CC.

No no no

That is my point. Trial start does not mean first patient dosed. CC has outlined in a previous communication the lengthy steps between IND approval and first in patient dosed.

My prediction is still for initial clinical results around June.

No deals until at least tolerance shown to some degree and even then maybe not until initial signs of efficacy.

And yes I do know that P1 is not designed to show efficacy.

Ginge

That would be great. Can you provide a link to where that is stated please.

I’m not challenging you. Because that would be good if they start in March.

Thanks

Clear from what CC said in today’s RNS that no one has been dosed with 6103 yet. Given the preparation work that needs to be carried out including pre screening, I previously predicted April earliest for dosing to start. (Based on 6100 timescales)

Watching

In your view each year for the past three years was the year we would be taken over🤡

It is so frustrating that it is taking so long to get this into the hospitals when it proved it’s safety and tolerability years ago.

CC made it clear what needed to happen to precipitate any deal and it won’t happen until the next set of clinical results are released.

So stop all this wishful ramping.

All hail the uber ramper.

But I agree with everything except I think his timeline is optimistic. I’m still saying Summer for the pivotal moment - in that respect I am accepting CC’s predictions.

More desperate ramping

Very cryptic. Public fund raise incoming?

Hooray

Common sense and rational analysis returns to the board.

Now why can’t we cease the nonsensical tribal warfare and wait patiently for this to play out

Why can’t the seasoned well informed investors on here understand that each time news is released is a time to review the risk/reward balance of an investment. Great RNS today moves the balance towards the reward side. Whether it is far enough to make you buy is up to your investment aims. It’s got nothing to do with loyalty or disloyalty towards Avacta. Or saving lives. It’s an investment decision that’s all. We aren’t supporting our favourite soccer team.

Well done to those who bought yesterday

This could bring a rise in SP that precipitates the fund raise. RNS on Thursday? CC loves a Thursday RNS

HarChris

As I recall doxorubicin worked well in a combined treatment for TNBC but the main issue was that despite destroying the tumours many patients died later because of collateral damage to organs. Hence why AVA6000 was seen as a potentially better treatment.

BV

So what was his outright lie today.

Just a reminder that BV has fallen in love with Avacta and continues to expect CC to deliver ahead of her stated predicted dates.

I thought the Q&A was fairly honest this time in terms of the science.